Barclays issued research notes on Synaptics stock, while MarketBeat aggregated consensus rating data, with news also reported on Benzinga.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays issued research notes on Synaptics stock, while MarketBeat aggregated consensus rating data, with news also reported on Benzinga.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Synaptics
technology company in the United States
-
Barclays
British bank
- QinetiQ carried out share purchases and arranged for a share buyback execution on the London Stock Exchange.
- Financial institutions provided ratings on multiple companies on July 8, 2026, including Goldman Sachs reiterating Tesla as neutral, Barclays initiating Toast as overweight, and Bank of America rating Nvidia as a buy.
-
MarketBeat
American personal finance blog
-
Benzinga
American news channel
Related events
- Benzinga reported on the financial performance of UnitedHealth Group, while MarketBeat aggregated consensus ratings and target prices.
- MarketBeat is aggregating consensus rating data for BrightView stock, and Morgan Stanley has begun investment banking analysis on the company.
- Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.
- MarketBeat is aggregating consensus ratings and targets for MINISO Group Holding Limited, while HSBC has published research reports on the company's stock.
- Benzinga reported on stock rating changes for Nvidia, while MarketBeat provided consensus rating data.